Original source 

Stem Cell Transplants May Delay Disability Longer Than Some MS Medications

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. It is a debilitating condition that can cause a range of symptoms, including fatigue, muscle weakness, and difficulty with coordination and balance. While there are several medications available to treat MS, a recent study has found that stem cell transplants may be more effective in delaying disability than some of these medications.

What is Multiple Sclerosis?

Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system. The immune system attacks the myelin sheath, which is the protective covering around nerve fibers. This damage disrupts the communication between the brain and the rest of the body, leading to a range of symptoms.

Current Treatments for Multiple Sclerosis

There are several medications available to treat MS, including interferons, glatiramer acetate, and dimethyl fumarate. These medications work by reducing inflammation and slowing down the progression of the disease. However, they are not effective for everyone and can have side effects.

Stem Cell Transplants for Multiple Sclerosis

Stem cell transplants involve taking stem cells from the patient's own body and then using chemotherapy to destroy the immune system. The stem cells are then reintroduced into the body, where they can rebuild the immune system. This process is known as autologous hematopoietic stem cell transplantation (AHSCT).

The Study

A recent study published in the journal Neurology compared the effectiveness of AHSCT to three medications commonly used to treat MS: natalizumab, fingolimod, and alemtuzumab. The study involved 110 patients with relapsing-remitting MS who had not responded to previous treatments.

The results showed that AHSCT was more effective in delaying disability than the three medications. After five years, 60% of the AHSCT group had not experienced disability progression, compared to 48% of the natalizumab group, 39% of the fingolimod group, and 26% of the alemtuzumab group.

Why Stem Cell Transplants May Be More Effective

Stem cell transplants may be more effective in delaying disability because they target the underlying cause of the disease. By rebuilding the immune system, they can prevent further damage to the myelin sheath and slow down the progression of the disease.

Conclusion

Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system. While there are several medications available to treat MS, a recent study has found that stem cell transplants may be more effective in delaying disability than some of these medications. Stem cell transplants involve taking stem cells from the patient's own body and then using chemotherapy to destroy the immune system. The stem cells are then reintroduced into the body, where they can rebuild the immune system. This process is known as autologous hematopoietic stem cell transplantation (AHSCT). The study showed that AHSCT was more effective in delaying disability than three medications commonly used to treat MS: natalizumab, fingolimod, and alemtuzumab. Stem cell transplants may be more effective because they target the underlying cause of the disease and can prevent further damage to the myelin sheath.

FAQs

1. What is multiple sclerosis?

Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system.

2. What are the current treatments for multiple sclerosis?

There are several medications available to treat MS, including interferons, glatiramer acetate, and dimethyl fumarate.

3. How does stem cell transplantation work?

Stem cell transplants involve taking stem cells from the patient's own body and then using chemotherapy to destroy the immune system. The stem cells are then reintroduced into the body, where they can rebuild the immune system.

4. What did the recent study on stem cell transplants and MS find?

The study showed that stem cell transplants may be more effective in delaying disability than some medications commonly used to treat MS.

5. Why might stem cell transplants be more effective?

Stem cell transplants may be more effective because they target the underlying cause of the disease and can prevent further damage to the myelin sheath.

This abstract is presented as an informational news item only and has not been reviewed by a medical professional. This abstract should not be considered medical advice. This abstract might have been generated by an artificial intelligence program. See TOS for details.

Most frequent words in this abstract:
medications (3), multiple (3), sclerosis (3), system (3)